Issue N# 2 - 2003
Nasal polyposis: long term functional results in 203 patients treated by ethmoïdectomy associated with intranasal corticotherapy.
Authors : M. Folia, L. Lombard, S. Vergès, J. Percodani, J. J. Pessey, E. Serrano (Toulouse)
Ref. : Rev Laryngol Otol Rhinol. 2003;124,2:105-110.
Article published in french
Downloadable PDF document french
Objective: Evaluate the long term quality of life in patients after ethmoidectomy associated with intranasal corticotherapy for nasal polyposis on the appreciation of the intensity of nasal symptoms. Material et method: The authors report their experience about 203 patients treated by endonasal endoscopic ethmoïdectomy intranasal followed by a long term intranasal corticotherapy, with a mean follow up of six years. In this prospective study, each symptom was evaluated using an analogic visual scale and a questionnaire. The evolution of asthma after surgery and the patients global satisfactory rate were noted. Results: there is a global improvement of the nasal symptoms with a mean postoperative individual scores calculated at 32% for nasal obstruction, at 34% for rhinorrhea and at 51% for anosmia. No impact on asthma or improvement of asthma was encountered in 92% of the patients. The patients global satisfactory rate of this medico-surgical approach of the disease is 93.6%. A positive correlation was found between the severity of the olfactory disorders and the oral corticosteroid therapy. Conclusion: Endoscopic endonasal ethmoïdectomy followed by intranasal corticotherapy represents a valuable protocol in treating patients with severe nasal polyposis.
Price : 10.50 €